June 4, 2024

 

dsm-firmenich's methane-reducing feed ingredient Bovaer^® ready for US market launch

 

The US Food and Drug Administration (FDA) announced it has completed its comprehensive, multi-year review of Bovaer^® (3-NOP), a first-in-class methane-reducing feed ingredient, and determined the product meets safety and efficacy requirements for use in lactating dairy cattle, dsm-firmenich said.

 

This paves the way for the company's strategic partner Elanco Animal Health Incorporated to launch Bovaer^® in the US market.

 

dsm-firmenich developed the feed ingredient which effectively and immediately reduces methane emissions from cattle, and thereby supporting the fight against climate change, while providing affordable nutrition, the company stated.

 

In 2022, dsm-firmenich and Elanco Animal Health Incorporated announced a strategic collaboration for the registration, marketing and sales, and longer-term production of Bovaer^® in the United States.

 

Dimitri de Vreeze, chief executive officer of dsm-firmenich, said: "We congratulate Elanco and the US dairy sector on this important milestone, and will support Elanco by providing initial supplies from Europe. Bovaer^® holds the key to a transformative shift in the global dairy sector, and launching this feed ingredient in the US after years of dedicated research, trials and industry collaboration is a testament to its global potential."

 

Jeff Simmons, president and CEO of Elanco Animal Health, said: "We appreciate the years of work dsm-firmenich has invested in Bovaer® and are pleased they've recognised Elanco as the right partner to bring this solution to farmers across North America.

 

"Bovaer^® represents another example of Elanco's highly effective research and regulatory capabilities delivering. We are excited to bring this revolutionary product to US dairy farmers, accelerating the opportunity for climate-neutral dairy farming. Bovaer^® will create value for farmers, while helping food companies meet consumer demands and deliver on their sustainability commitments."

 

dsm-firmenich said it is also pleased to have further expanded its collaboration with Elanco from the US to also include Mexico and Canada. Many customers are organised as a North American operation, and with this geographical expansion of the collaboration with Elanco, customers will be more seamlessly served.

 

Mark van Nieuwland, vice president of Bovaer^® at dsm-firmenich, said: "This strategic collaboration exemplifies how we can accelerate the expansion and adoption of Bovaer^® to significantly decrease methane emissions on a large scale, and thereby support global efforts to combat climate change. We will continuously explore opportunities in our go-to-market approach to further accelerate making Bovaer^® available for farmers globally."

Bovaer^® is now commercially available in 59 countries including the US, the European Union, the United Kingdom, Canada, Mexico, Australia and most of Latin America.

- dsm-firmenich